DNA Probes based Diagnostics Market
DNA Probes based Diagnostics Market - By Application & Global Region - Market Size, Trends, Opportunity, Historical Review and Forecast 2022-2027Request Sample Request Discount
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the DNA Probes based Diagnostics MarketRequest Sample
The stretches of single-stranded DNA are known as DNA probes and are utilized to identify complementary nucleic acid sequences by means of hybridization. They are marked with a label like fluorescence or color. These probes allow researchers to detect a distinct in a mixture, a specific DNA. To separate the DNA strands, the DNA sample is heated, after which the probe is applied.
Investments have increased due to the growing adoption of DNA probes in new disease identification and new players' foray. In diagnostics as well in other fields such as micro-fabrication, data handling, molecular biology, instrumentation development, biological sample preparation, and surface chemistry, the DNA probes-based technology is used extensively. Thus, there is the immense popularity of DNA probes-based technology in the last few years. Moreover, increasing awareness of the technology for prenatal diagnosis and carrier detection is growing rapidly and it will have a significant impact on the demand and growth of this technology.
Also increased automation in diagnosis tests is likely to create lucrative growth opportunities for the global DNA probes-based diagnostics market and this market is expected to grow at a growth rate of over 5% during the period from 2022 to 2027. Due to the burgeoning healthcare expenditure across countries, the DNA probes diagnostics market has lucrative opportunities to expand.
For the precise detection of infections, DNA probes-based diagnostics are gaining immense popularity. This is because antibiotic resistance is the biggest threat to global health and the new resistance mechanisms are developing and expanding globally, thus hampering the ability to treat widespread infectious diseases. The annual fatalities from antimicrobial-resistant infections will rise drastically unless preventive measures are effectively implemented, and the DNA probes are especially useful in the accurate detection and diagnosis of infectious diseases.
The elderly population is rising globally due to declining fertility rates and increased life expectancy. Older people have several health issues, and this population is likely to grow in the coming years. As a result of this the market for DNA Probes based diagnostics is expected to grow. This is also because of rising disposable income and as a result of this, there is a demand for DNA probes-based diagnostics. In the global healthcare industry, the DNA probes have been a welcome development; there are potential demerits associated with the
DNA probes-based diagnostics, which is likely to hamper the expansion of the market soon. The attractive market for DNA probes-based diagnostics is the United States as there is high incidence rate of genetic disorders in the country, leading to congenital disabilities, developmental disabilities, and other metabolic syndromes are some of the factors to the growth in the US. Moreover, investments have increased in pharmaceuticals and pharmacogenomics research and development. Thus, the global market for DNA probes-based diagnostics will increase. Due to the increasing prominence of technology in diagnosing infectious diseases, including vaginitis, the global DNA probes diagnostics market is likely to grow.
Based on application, the market is segmented into infectious diseases, cancer, genetic predisposition, identity/forensics and others. Infectious diseases segment is anticipated to witness significant growth during the forecast period. This can be attributed to rising number of infectious diseases across the globe. Moreover, increasing old age population is envisioned to positively impact the growth of market.
Key Market Players
The key market players are:
- Abbott Laboratories
- Beckman Coulter Inc.
- Becton Dickinson & Company
- F Hoffmann-La Roche Ltd.
- GE Healthcare Life Sciences
- Luminex Corporation
- Qiagen NV
- Siemens Healthineers
- Thermofisher Scientific Inc.
- Infectious Diseases
- Genetic Predisposition
- North America (The U.S. and Canada)
- Europe (U.K., Germany, France, Italy, Spain, Russia, Poland, Turkey, Switzerland, and Rest of Europe)
- Asia Pacific (Japan, China, India, Australia, South Korea, Vietnam, Philippines, Malaysia, Indonesia, Thailand, and Rest of Asia Pacific)
- Latin America (Brazil, Mexico, Columbia, Argentina, Chile, and Rest of Latin America)
- Middle East & Africa (South Africa, Saudi Arabia, UAE, Oman, Egypt, and Rest of Middle East & Africa)
Powered by Froala Editor
Powered by Froala Editor
Custom Research Requirement? Questions to ask?Get in touch
Custom Research requirement.